Celiac Disease by the Age of 13 Years Is Not Associated with Probiotics Administration in Infancy

Journal of Pediatric Gastroenterology and Nutrition

Volumn 66, Issue 6, 2018, Pages 937-940

  Savilahti, Emma Merike ^a   Ilonen, Jorma ^b   Kukkonen, Anna Kaarina ^a   Savilahti, Erkki ^a   Kuitunen, Mikael ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

allergy; clinical trial; early feeding; primary prevention; prospective

Indexed keywords

ANTIBIOTIC AGENT; HLA DQ2 ANTIGEN; HLA DQ2.2 ANTIGEN; HLA DQ2.5 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; PROBIOTIC AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG; PREBIOTIC AGENT;

ADOLESCENT; ALLERGIC DISEASE; ANTIBIOTIC THERAPY; ARTICLE; BREAST FEEDING; CELIAC DISEASE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEEDING; FEMALE; FOLLOW UP; GENOTYPE; HLA SYSTEM; HUMAN; INFANCY; INSULIN DEPENDENT DIABETES MELLITUS; LIMIT OF DETECTION; MALE; PREGNANT WOMAN; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SKIN SENSITIZATION; THIRD TRIMESTER PREGNANCY; INFANT; INFANT CARE; PREGNANCY; PRENATAL CARE; PROCEDURES; TREATMENT OUTCOME;

CELIAC DISEASE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT CARE; MALE; PREBIOTICS; PREGNANCY; PRENATAL CARE; PREVALENCE; PRIMARY PREVENTION; PROBIOTICS; TREATMENT OUTCOME;

EID: 85042640977     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001846     Document Type: Article

References (20)

1. Husby S, Koletzko S, Korponay-Szabo IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54:136-60.
2. Lionetti E, Castellaneta S, Francavilla R, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 2014;371:1295-303.
3. Aronsson CA, Lee HS, Liu E, et al. Age at gluten introduction and risk of celiac disease. Pediatrics 2015;135:239-45.
4. Troncone R, Discepolo V. Celiac disease and autoimmunity. J Pediatr Gastroenterol Nutr 2014;59(Suppl 1):S9-11.
5. Zauli D, Grassi A, Granito A, et al. Prevalence of silent coeliac disease in atopics. Dig Liver Dis 2000;32:775-9.
6. Canova C, Pitter G, Ludvigsson JF, et al. Coeliac disease and asthma association in children: the role of antibiotic consumption. Eur Respir J 2015;46:115-22.
7. Marild K, Kahrs CR, Tapia G, et al. Infections and risk of celiac disease in childhood: a prospective nationwide cohort study. Am J Gastroenterol 2015;110:1475-84.
8. Welander A, TjernbergAR,MontgomerySM, et al. Infectious disease and risk of later celiac disease in childhood. Pediatrics 2010;125:e530-6.
9. Canova C, Zabeo V, Pitter G, et al. Association of maternal education, early infections, and antibiotic use with celiac disease: a population-based birth cohort study in northeastern Italy. Am J Epidemiol 2014;180:76-85.
10. Cenit MC, Codoner-Franch P, Sanz Y. Gut Microbiota and Risk of Developing Celiac Disease. J Clin Gastroenterol. 2016; 50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S148-52.
11. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007;119:192-8.
12. Kuitunen M, Kukkonen K, Juntunen-Backman K, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009;123:335-41.
13. Kolho KL, Savilahti E. IgA endomysium antibodies on human umbilical cord: an excellent diagnostic tool for celiac disease in childhood. J Pediatr Gastroenterol Nutr 1997;24:563-7.
14. Kiviniemi M, Hermann R, Nurmi J, et al. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007;9:460-72.
15. Collado MC, Donat E, Ribes-Koninckx C, et al. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009;62:264-9.
16. Di Cagno R, De Angelis M, De Pasquale I, et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol 2011;11:219.
17. Palma GD, Capilla A, Nova E, et al. Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS One 2012;7:e30791.
18. Emilsson L, Magnus MC, Stordal K. Perinatal risk factors for development of celiac disease in children, based on the prospective Norwegian Mother and Child Cohort Study. Clin Gastroenterol Hepatol 2015;13:921-7.
19. Decker E, Engelmann G, Findeisen A, et al. Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics 2010;125:e1433-40.
20. Maki M, Mustalahti K, Kokkonen J, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med 2003;348:2517-24.